Shuttle Pharmaceuticals Inc. (SHPH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Shuttle Pharmaceuticals ...

    NASDAQ: SHPH · Real-Time Price · USD
    4.42
    0.04 (0.91%)
    At close: Sep 24, 2025, 3:59 PM
    4.30
    -2.82%
    After-hours: Sep 24, 2025, 06:27 PM EDT

    Shuttle Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 5.46K 6.81K 5.97K 60.83K
    Gross Profit
    		 -5.46K -6.81K -66.83K -60.83K
    Operating Income
    		 -7.7B -5.89M -2.34M -1.74M
    Interest Income
    		 38.14K 79.12K n/a n/a
    Pretax Income
    		 -9.14B -6.59M -5M -1.15M
    Net Income
    		 -9.14B -6.59M -3.1M -1.15M
    Selling & General & Admin
    		 1.39B 1.05M 1.07M 721.18K
    Research & Development
    		 3.62M 3.52M 1.05M 1.02M
    Other Expenses
    		 -1.39B 1.32M 224.72K -60.83K
    Operating Expenses
    		 7.69M 5.89M 2.34M 1.68M
    Interest Expense
    		 1.36M 2.6M 670.61K 50.79K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 7.7M 5.89M 2.34M 1.74M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 10.32M 15.91M 10.35M 13.59M
    Shares Outstanding (Diluted)
    		 10.32M 15.91M 10.35M 13.59M
    EPS (Basic)
    		 -885.73 -0.41 -0.3 -0.09
    EPS (Diluted)
    		 -885.73 -0.41 -0.3 -0.09
    EBITDA
    		 -7.78M -3.99M -4.32M -1.04M
    EBIT
    		 -7.78M -4M -4.33M -1.1M
    Depreciation & Amortization
    		 5.46K 6.81K 5.97K 60.83K

    Add to Watchlist